PRICES include / exclude VAT
>UNE standards>UNE EN ISO 21535:2025 - Non-active surgical implants - Joint replacement implants - Specific requirements for hip-joint replacement implants (ISO 21535:2023)
in stockReleased: 2025-01-22
UNE EN ISO 21535:2025 - Non-active surgical implants - Joint replacement implants - Specific requirements for hip-joint replacement implants (ISO 21535:2023)

UNE EN ISO 21535:2025

Non-active surgical implants - Joint replacement implants - Specific requirements for hip-joint replacement implants (ISO 21535:2023)

Implantes quirúrgicos no activos. Implantes de sustitución articular. Requisitos específicos para los implantes de sustitución de la articulación de cadera. (ISO 21535:2023).

Format
Availability
Price and currency
English PDF
Immediate download
Printable
120.12 EUR
English Hardcopy
In stock
120.12 EUR
Spanish PDF
Immediate download
Printable
100.10 EUR
Spanish Hardcopy
In stock
100.10 EUR
Standard number:UNE EN ISO 21535:2025
Pages:42
Released:2025-01-22
Status:Standard
Pages (Spanish):44
DESCRIPTION

UNE EN ISO 21535:2025

This document provides specific requirements for hip joint replacement implants. With regard to safety, this document specifies requirements for intended performance, design attributes, materials, design evaluation, manufacture, sterilization, packaging, information supplied by the manufacturer, and methods of test. This document applies to both total and partial hip joint replacement implants. It applies to components made of metallic and non-metallic materials. This document applies to a wide variety of hip replacement implants, but for some specific hip replacement implant types, some considerations, not specifically covered in this document, may be applicable. Further details are given in Clause 7.2.1.1. The requirements which are specified in this document are not intended to require the re-design or re-testing of devices which have been legally marketed and for which there is a history of sufficient and safe clinical use. For such devices compliance with this document shall be demonstrated by providing evidence of the sufficient and safe clinical use.